2-[2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]acetic acid;2-[2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]-N-(4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-ylmethyl)acetamide;4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-ylmethanamine
C56H60N10O5S2 — CID 159814750
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]acetic acid;2-[2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]-N-(4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-ylmethyl)acetamide;4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-ylmethanamine
2-[2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]acetic acid;2-[2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]-N-(4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-ylmethyl)acetamide;4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-ylmethanamine (PubChem CID 159814750) has the molecular formula C56H60N10O5S2 and a molecular weight of 1017.29 g/mol. Its IUPAC name is 2-[2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]acetic acid;2-[2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]-N-(4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-ylmethyl)acetamide;4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-ylmethanamine.
Molecular Properties
| Compound Name | 2-[2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]acetic acid;2-[2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]-N-(4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-ylmethyl)acetamide;4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-ylmethanamine |
|---|---|
| PubChem CID | 159814750 |
| Molecular Formula | C56H60N10O5S2 |
| Molecular Weight | 1017.29 g/mol |
| Exact Mass | 1016.42 |
| IUPAC Name | 2-[2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]acetic acid;2-[2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]-N-(4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-ylmethyl)acetamide;4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-ylmethanamine |
| SMILES | NCc1cc2c(s1)CNCC2.O=C(Cn1c(-c2ccccc2)cnc(NCCc2ccccc2)c1=O)NCc1cc2c(s1)CNCC2.O=C(O)Cn1c(-c2ccccc2)cnc(NCCc2ccccc2)c1=O |
| InChI | InChI=1S/C28H29N5O2S.C20H19N3O3.C8H12N2S/c34-26(31-16-23-15-22-12-13-29-18-25(22)36-23)19-33-24(21-9-5-2-6-10-21)17-32-27(28(33)35)30-14-11-20-7-3-1-4-8-20;24-18(25)14-23-17(16-9-5-2-6-10-16)13-22-19(20(23)26)21-12-11-15-7-3-1-4-8-15;9-4-7-3-6-1-2-10-5-8(6)11-7/h1-10,15,17,29H,11-14,16,18-19H2,(H,30,32)(H,31,34);1-10,13H,11-12,14H2,(H,21,22)(H,24,25);3,10H,1-2,4-5,9H2 |
| InChIKey | NLLXKJUGVORCPH-UHFFFAOYSA-N |
| XLogP | 7.09 |
| TPSA | 210.32 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 73 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1017.29 |
| LogP ≤ 5 | 7.09 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 15 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159814750 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.